REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Dreembio S.A.S (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Dreembio S.A.S Profile Updated: May 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Dreembio S.A.S is based in Colombia, with the head office in Bogota D.C.. The enterprise operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was first established on April 09, 2019. Dreembio S.A.S currently employs 2 (2023) people. The latest financial highlights indicate a net sales revenue increase of 74.86% in 2023. Its’ total assets recorded a negative growth of 3.17%. The net profit margin of Dreembio S.A.S increased by 120.08% in 2023.

Headquarters
Cr 52 B # 118 74
Bogota D.C.; Bogota D.C; Postal Code: 1015

Contact Details: Purchase the Dreembio S.A.S report to view the information.

Basic Information
Total Employees:
Purchase the Dreembio S.A.S report to view the information.
Outstanding Shares:
Purchase the Dreembio S.A.S report to view the information.
Incorporation Date:
April 09, 2019
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Deputy Member of the Board of Directors
Company Performance
Financial values in the chart are available after Dreembio S.A.S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
74.86%▲
Total operating revenue
74.86%▲
Operating profit (EBIT)
11.44%▲
Net Profit (Loss) for the Period
12.52%▲
Total assets
-3.17%▼
Total equity
-3.8%▼
Operating Profit Margin (ROS)
117.14%▲
Net Profit Margin
120.08%▲
Return on Equity (ROE)
0.38%▲
Quick Ratio
-7.54%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo